Categories
Nevin Manimala Statistics

Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck

JAMA Oncol. 2023 Nov 22. doi: 10.1001/jamaoncol.2023.5401. Online ahead of print.

NO ABSTRACT

PMID:37991750 | DOI:10.1001/jamaoncol.2023.5401

By Nevin Manimala

Portfolio Website for Nevin Manimala